HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated bilirubin levels are associated with a better renal prognosis and ameliorate kidney fibrosis.

AbstractBACKGROUND:
Bilirubin has been reported to protect against kidney injury. However, further studies highlighting the beneficial effects of bilirubin on renal fibrosis and chronic renal function decline are necessary.
METHODS:
We assessed a prospective cohort with a reference range of total bilirubin levels. The primary outcome was a 30% reduction in the estimated glomerular filtration rate (eGFR) from baseline, and the secondary outcome was a doubling of the serum creatinine levels, halving of the eGFR and the initiation of dialysis. In addition, experiments with tubular epithelial cells and C57BL/6 mice were performed to investigate the protective effects of bilirubin on kidney fibrosis.
RESULTS:
As a result, 1,080 patients were included in the study cohort. The study group with relative hyperbilirubinemia (total bilirubin 0.8-1.2 mg/dL) showed a better prognosis in terms of the primary outcome (adjusted hazard ratio (HR) 0.33, 95% confidence interval (CI) 0.19-0.59, P < 0.001) and the secondary outcome (adjusted HR 0.20, 95% CI 0.05 to 0.71, P = 0.01) than that of the control group. Moreover, the bilirubin-treated mice showed less fibrosis in the unilateral ureteral obstruction (UUO) model (P < 0.05). In addition, bilirubin treatment decreased fibronectin expression in tubular epithelial cells in a dose-dependent manner (P < 0.05).
CONCLUSIONS:
Mildly elevated serum bilirubin levels were associated with better renal prognosis, and bilirubin treatment induced a beneficial effect on renal fibrosis. Therefore, bilirubin could be a potential therapeutic target to delay fibrosis-related kidney disease progression.
AuthorsSehoon Park, Do Hyoung Kim, Jin Ho Hwang, Yong-Chul Kim, Jin Hyuk Kim, Chun Soo Lim, Yon Su Kim, Seung Hee Yang, Jung Pyo Lee
JournalPloS one (PLoS One) Vol. 12 Issue 2 Pg. e0172434 ( 2017) ISSN: 1932-6203 [Electronic] United States
PMID28225832 (Publication Type: Journal Article)
Chemical References
  • Creatinine
  • Bilirubin
Topics
  • Aged
  • Animals
  • Apoptosis (drug effects)
  • Bilirubin (blood, pharmacology)
  • Creatinine (blood)
  • Disease Models, Animal
  • Disease Progression
  • Female
  • Fibrosis (blood, pathology, physiopathology)
  • Glomerular Filtration Rate (physiology)
  • Humans
  • Kidney (drug effects, pathology, physiopathology)
  • Kidney Diseases (blood, pathology, physiopathology)
  • Kidney Function Tests
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Middle Aged
  • Prognosis
  • Prospective Studies
  • Renal Insufficiency, Chronic (blood, pathology, physiopathology)
  • Ureteral Obstruction (blood, pathology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: